Skip to main content
NCBI home page
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2004 May;21(5):163–168. doi: 10.1023/B:JARG.0000031249.37862.3a

Feasibility of Human Telomerase Reverse Transcriptase mRNA Expression in Individual Blastomeres as an Indicator of Early Embryo Development

Chia-Woei Wang 1, Ding-Shyan Yao 1, Shang-Gwo Horng 1, Hsiao-Chen Chiu 2, Chun-Kai Chen 1, Chyi-Long Lee 1, Hong-Yuan Huang 1, Hsin-Shih Wang 1, Yung-Kuei Soong 1, Chia C Pao 1
PMCID: PMC3455524  PMID: 15279323

Abstract

Patients: The study was undertaken to test whether human telomerase reverse transcriptase (hTERT) transcripts in an individual blastomere could be used as an indicator for embryo development.

Methods: Group A consisted of day 3 normal cleaving embryos at 4- to 8-cell stage, which were surplus and not allocated for uterine transfer. Group B consisted of arrested or fragmented embryos at the same stage, which were considered to be compromised. After blastomere dissociation, RNA purification, reverse transcription, and hTERT PCR amplification, the amplified product was separated by 3% gel electrophoresis.

Results: Eighty-six (90.5%) of the 95 intact blastomeres in group A and 78 (70.9%) of the 110 blastomeres in group B demonstrated hTERT mRNA expression. The difference was statistically significant (P< 0.05, chi-square). Eight (38.1%) of the 21 embryos in group A and 22 (62.9%) of the 35 embryos in group B had at least one blastomere that did not express hTERT mRNA under this procedure. The difference was not significant (P> 0.05, chi-square).

Conclusions: General hTERT mRNA transcripts can be detected in most of the individual blastomeres but cannot be used as an indicator for early embryo development. Further investigations are necessary to elucidate its clinical application.

Keywords: Embryo development, hTCS, hTERT, telomerase activity

Full Text

The Full Text of this article is available as a PDF (112.9 KB).

References

  • 1.Zakian VA. Telomeres: Beginning to understand the end. Science. 1995;270:1601–1607. doi: 10.1126/science.270.5242.1601. [DOI] [PubMed] [Google Scholar]
  • 2.Preston RJ. Telomeres, telomerase and chromosome stability. Radiat Res. 1997;147:529–534. [PubMed] [Google Scholar]
  • 3.Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature. 1990;345:458–460. doi: 10.1038/345458a0. [DOI] [PubMed] [Google Scholar]
  • 4.Faragher RG, Kipling D. How might replicative senescence contribute to human aging? Bioessays. 1998;20:985–991. doi: 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  • 5.Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell. 1989;59:521–529. doi: 10.1016/0092-8674(89)90035-4. [DOI] [PubMed] [Google Scholar]
  • 6.Dahse R, Fiedler W, Ernst G. Telomeres and telomerase: Biological and clinical importance. Clin Chem. 1997;43:708–714. [PubMed] [Google Scholar]
  • 7.Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011–2015. doi: 10.1126/science.7605428. [DOI] [PubMed] [Google Scholar]
  • 8.Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol. 1997;50:106–109. doi: 10.1136/jcp.50.2.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fossel M. Telomerase and the aging cell: Implications for human health. JAMA. 1998;279:1732–1735. doi: 10.1001/jama.279.21.1732. [DOI] [PubMed] [Google Scholar]
  • 10.Weinberg RA. Telomeres. Bumps on the road to immortality. Nature. 1998;396:23–24. doi: 10.1038/23825. [DOI] [PubMed] [Google Scholar]
  • 11.Fujisawa M, Tanaka H, Tatsumi N, Okada H, Arakawa S, Kamidono S. Telomerase activity in the testis of infertile patients with selected causes. Hum Reprod. 1998;13:1476–1479. doi: 10.1093/humrep/13.6.1476. [DOI] [PubMed] [Google Scholar]
  • 12.Brenner CA, Wolny YM, Adler RR, Cohen J. Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos. Mol Hum Reprod. 1999;5:845–850. doi: 10.1093/molehr/5.9.845. [DOI] [PubMed] [Google Scholar]
  • 13.Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18:173–179. doi: 10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  • 14.Xu J, Yang X. Telomerase activity in bovine embryos during early development. Biol Reprod. 2000;63:1124–1128. doi: 10.1095/biolreprod63.4.1124. [DOI] [PubMed] [Google Scholar]
  • 15.Hardy K, Martin KL, Leese HJ, Winston RM, Handyside AH. Human preimplantation development in vitro is not adversely affected by biopsy at the 8-cell stage. Hum Reprod. 1990;5:708–714. doi: 10.1093/oxfordjournals.humrep.a137173. [DOI] [PubMed] [Google Scholar]
  • 16.Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science. 1997;277:955–959. doi: 10.1126/science.277.5328.955. [DOI] [PubMed] [Google Scholar]
  • 17.Meyerson N, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997;90:785–795. doi: 10.1016/s0092-8674(00)80538-3. [DOI] [PubMed] [Google Scholar]
  • 18.Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997;6:2011–2019. doi: 10.1093/hmg/6.12.2011. [DOI] [PubMed] [Google Scholar]
  • 19.Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu C, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349–352. doi: 10.1126/science.279.5349.349. [DOI] [PubMed] [Google Scholar]
  • 20.Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol. 2003;162:1019–1026. doi: 10.1016/S0002-9440(10)63896-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wright DL, Jones EL, Mayer JF, Oehninger S, Gibbons WE, Lanzendorf SE. Characterization of telomerase activity in the human oocyte and preimplantation embryo. Mol Hum Reprod. 2001;7:947–955. doi: 10.1093/molehr/7.10.947. [DOI] [PubMed] [Google Scholar]
  • 22.Eisenhauer KM, Gerstein RM, Chiu CP, Conti M, Hsueh AJ. Telomere activity in female and male rat germ cells undergoing meiosis and in early embryos. Biol Reprod. 1997;56:1120–1125. doi: 10.1095/biolreprod56.5.1120. [DOI] [PubMed] [Google Scholar]
  • 23.Betts DH, King WA. Telomerase activity and telomere detection during early bovine development. Dev Genet. 1999;25:397–403. doi: 10.1002/(SICI)1520-6408(1999)25:4<397::AID-DVG13>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  • 24.Giorgetti C, Terriou P, Auquier P, Hans E, Spach JL, Salzmann J, Roulier R. Embryo score to predict implantation after in vitro fertilization: Based on 957 single embryo transfers. Hum Reprod. 1995;10:2427–2431. doi: 10.1093/oxfordjournals.humrep.a136312. [DOI] [PubMed] [Google Scholar]
  • 25.Visser DS, Fourie FR. The applicability of the cumulative embryo score system for embryo selection and quality control in an in vitro fertilization/embryo transfer programme. Hum Reprod. 1993;8:1719–1722. doi: 10.1093/oxfordjournals.humrep.a137922. [DOI] [PubMed] [Google Scholar]
  • 26.Bolton VN, Hawes SM, Taylor CT, Parsons JH. Development of spare human preimplantation embryos in vitro: An analysis of the correlations among gross morphology, cleavage rate, and development to the blastocyst. J In Vitro Fert Embryo Transf. 1989;6:30–35. doi: 10.1007/BF01134578. [DOI] [PubMed] [Google Scholar]
  • 27.Leese HJ. Analysis of embryos by non-invasive methods. Hum Reprod. 1987;2:37–40. doi: 10.1093/oxfordjournals.humrep.a136485. [DOI] [PubMed] [Google Scholar]
  • 28.Conaghan J, Hardy K, Handyside AH, Winston RM, Leese HJ. Selection criteria for human embryo transfer: A comparison of pyruvate uptake and morphology. J Assist Reprod Genet. 1993;10:21–30. doi: 10.1007/BF01204436. [DOI] [PubMed] [Google Scholar]
  • 29.Grifo JA, Boyle A, Fischer E, Lavy G, DeCherney AH, Ward DC, Sanyal MK. Preembryo biopsy and analysis of blastomeres by in situ hybridization. Am J Obstet Gynecol. 1990;163:2013–2019. doi: 10.1016/0002-9378(90)90789-a. [DOI] [PubMed] [Google Scholar]
  • 30.Hisatomi H, Nagao K, Kanamaru T, Hiyama E. Levels of telomerase catalytic subunit mRNA as a predictor of potential malignancy. Int J Oncol. 1999;14:727–732. doi: 10.3892/ijo.14.4.727. [DOI] [PubMed] [Google Scholar]
  • 31.Hartshorne GM. Factors controlling embryo viability. Hum Fertil. 2001;4:225–234. doi: 10.1080/1464727012000199571. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES